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Background: Mastitis endangers the health of domestic animals and humans, and may cause problems concerning
food safety. It is documented that n-3 polyunsaturated fatty acids (PUFA) play significant roles in attenuating
saturated fatty acids (SFA)-induced inflammation. This study was therefore conducted to determine whether
mammary inflammation could be affected by consumption of diets rich in n-3 PUFA.
Methods: Forty-eight rats after mating began to receive diets supplemented with 5% fish oil (FO) or 7%
soybean oil (SO). Blood and mammary tissue samples (n = 6) at day 0 and 14 of gestation and day 3
postpartum were collected 9 hours after intramammary infusion of saline or lipopolysaccharide (LPS) to
determine free fatty acids (FFA) concentration and FA composition in plasma and inflammation mediators in
mammary tissues.
Results: At day 14 of gestation and day 3 postpartum, the FO-fed rats had lower plasma concentrations of
C18:2n6, C20:4n6, total n-6 PUFA and SFA, and higher plasma concentrations of C20:5n3 and total n-3 PUFA
than the SO-fed rats. Plasma C22:6n3 concentration was also higher in the FO-fed than in the SO-fed rats at
day 3 postpartum. Compared with the SO-fed rats, the FO-fed rats had lower mammary mRNA abundance of
xanthine oxidoreductase (XOR) and protein level of tumor necrosis factor (TNF)-α, but had higher mammary
mRNA abundances of interleukin (IL)-10 and peroxisome proliferator-activated receptor (PPAR)-γ at day 14 of
gestation. Following LPS infusion at day 3 postpartum, the SO-fed rats had increased plasma concentrations of
FFA, C18:1n9, C18:3n3, C18:2n6 and total n-6 PUFA, higher mammary mRNA abundances of IL-1β, TNF-α and
XOR but lower mammary mRNA abundance of IL-10 than the FO-fed rats.
Conclusions: Mammary inflammation around parturition appeared to be attenuated by consumption of a diet
rich in n-3 PUFA, which was associated with up-regulated expression of IL-10 and PPAR-γ.
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Udder health is pivotal to productivity, antibiotic use
and animal welfare [1]. Mastitis threatens the health of
mammals all over the world including humans. For the
dairy industry, mastitis is the most costly common dis-
ease, and the economic loss due to mastitis in dairy* Correspondence: fangzhengfeng@hotmail.com
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stated.cattle is estimated at $185/cow/year in the United States
[2]. For the pork industry, the infection of the mam-
mary glands results in reduced productivity of sows
and increased mortality of piglets [3]. Up to a third
of lactating women will become ill because of mastitis
[4]. The occurrence of mastitis is characterized by red-
ness, swelling, and pain. However, without these symp-
toms, subclinical mastitis can also endanger the health
of mammals, characterized by a high somatic cell count
[5]. Owing to its invisible characteristic, subclinical mas-
titis may be neglected and bring even larger economic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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otics [6], which may lower the quality of animal products,
and threaten the health of humans. Thus, new methods
dealing with clinical and subclinical mastitis are urgently
needed.
It is generally considered that exogenous pathogens
are the main causes of mastitis, as E.coli and staphylococcusTable 1 Plasma FA composition (μg/mL) of rats fed different
Item Group Day 0 of gestation Day
C14:0 SO 30.69a 28.54
FO 14.35b 18.22
C16:0 SO 822.89a 738.6
FO 432.50c 455.6
C18:0 SO 588.93a 526.7
FO 342.09b 311.5
C20:0 SO 21.42a 10.30
FO 6.33b 6.71b
SFA SO 1463.92a 1304
FO 795.28b 792.1
C16:1 SO 59.10a 47.62
FO 42.06ab 42.55
C18:1n7 SO 27.86ab 23.04
FO 23.01b 20.98
C18:1n9 SO 191.83 177.4
FO 198.23 203.3
C20:1 SO 30.67ab 26.84
FO 10.95cd 12.91
MUFA SO 309.46 274.9
FO 274.25 279.7
C18:3n3 SO 8.99abc 10.82
FO 7.07bc 8.42a
C20:5n3 SO 7.59b 5.32b
FO 26.62b 87.73
C22:6n3 SO 40.45b 37.53
FO 73.89b 63.54
n-3 PUFA SO 64.84c 54.74
FO 107.58bc 159.6
C18:2n6 SO 253.41a 230.1
FO 235.76a 163.2
C20:4n6 SO 257.71b 233.2
FO 246.19b 116.0
n-6 PUFA SO 511.12b 463.4
FO 481.95bc 279.3
TFA SO 2349.34ab 2097
FO 1704.65bc 1510
1 Values of a certain fatty acid assigned no common superscript letter differ significhave been confirmed to play key roles in inducing mas-
titis in domestic animals [6,7]. These microorganisms
may activate the mammary innate immune systems and
thus cause inflammatory responses. Lipopolysaccharide
(LPS) has been used as the agonist in construction of
mastitis models in vivo and in vitro [7,8]. Recent stud-
ies indicated that in addition to LPS, saturated fattydiets at different reproductive stages1
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Figure 1 Plasma FFA concentration of rats fed different diets at
different reproductive stages. Plasma FFA concentration was
determined by ELISA using plasma collected from rats fed the SO or
FO diet at day 0 of gestation, day 14 of gestation and day 3
postpartum. Statistics are shown as means ± SE. Statistics with no
common letters differ significantly (P < 0.05).
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http://www.lipidworld.com/content/12/1/190acids (SFA) could also activate Toll-like-receptor (TLR)
4 signaling pathway through regulation of receptor
dimerization and recruitment into lipid rafts in a react-
ive oxygen species (ROS)-dependent manner [9]. Fur-





































































Figure 2 Relative mRNA abundances of rats fed different diets at diff
IL-10 (C) and PPAR-γ (D) was determined by RT-PCR with mammary tissues
Statistics are shown as means ± SE. Statistics with no common letters differand LPS on monocytes resulted in about 3-fold higher
mRNA and protein expression of pro-inflammatory
cytokines than the sum of individual responses to SFA
and LPS, indicating nutrient modification of TLR4–
mediated inflammation [10]. It was reported that SFA
were enriched in milk of mice fed western diet, and trig-
gered ceramide accumulation and inflammation in the ne-
onates [11]. Notably, the neonatal toxicity requires TLR
but not microbiota [11], suggesting that SFA may induce
inflammatory responses independent of exogenous patho-
gens. Studies in vivo and in vitro have demonstrated
that n-3 polyunsaturated fatty acids (PUFA) could block
SFA- and/or LPS-induced TLR signalling and attenuate
inflammation [12]. However, little is known about whether
the mammary inflammation induced by nutrients such as
SFA and pathogens such as LPS could be attenuated by
consumption of diets rich in n-3 PUFA.
Therefore, the objectives of the present study were to
evaluate the interactive effect of diets and reproductive
stages on fatty acids (FA) metabolism and inflamma-
tion as well as to determine the effect of dietary n-3
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erent reproductive stages. mRNA abundances of IL-8 (A), XOR (B),
collected from rats fed the SO or FO diet at day 0 and 14 of gestation.
significantly (P < 0.05).
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Effect of diet type on plasma FA composition at different
reproductive stages
Consumption of the SO diet increased plasma con-
centrations of C20:4n6 and total n-6 PUFA at day 3
postpartum (Table 1). In contrast, consumption of the
FO diet increased plasma concentrations of C20:5n3
from day 14 of gestation and C22:6n3 at day 3 post-
partum. Compared with the SO-fed rats, the FO-fed
rats had lower plasma concentration of C16:0 at day 0
of gestation and day 3 postpartum, concentrations of
C18:2n6, C20:4n6 and total n-6 PUFA at day 14 of
gestation and day 3 postpartum, and concentrations
of C18:0 and total SFA at the three time points evalu-
ated, but had higher plasma concentration of C22:6n3
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Figure 3 Immunohistochemical localization of IL-1β in udder of rats
microphotograph from one rat with the positive primary IL-1β antibody
mammary tissues of rats fed the SO diet (B) or FO diet (C) at day 0 an
production is presented as the average percentage of the positively stai
common letters differ significantly (P < 0.05).and total n-3 PUFA at day 14 of gestation and day 3
postpartum.
Effect of reproductive stages and diet type on plasma
FFA concentration and inflammation mediators in rat
mammary glands
Plasma FFA concentration in both groups was higher at
day 3 postpartum than at day 0 and 14 of gestation, with
no difference observed between groups at each of the
time points evaluated (Figure 1). In both groups, the
mRNA abundances of IL-8 and xanthine oxidoreductase
(XOR) (Figure 2), the protein levels of IL-1β (Figure 3) and
TNF-α (Figure 4) as well as PMN prevalence (Figure 5)
were higher at day 14 of gestation than at day 0 of gesta-
tion. Compared with the SO-fed rats, the FO-fed rats
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Figure 4 Immunohistochemical localization of TNF-α in udder of rats fed different diets at different reproductive stages. The
microphotograph from one rat with the positive primary TNF-α antibody was visualized with DAB reaction. The area positive for TNF-α in
mammary tissues of rats fed the SO diet (B) or FO diet (C) at day 0 and14 of gestation was quantified by Easy Image 3000 software. TNF-α
production is presented as the average percentage of the positively stained areas (A). Statistics are shown as means ± SE. Statistics with no
common letters differ significantly (P < 0.05).
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mammary mRNA abundances of IL-10 and peroxisome
proliferator-activated receptor (PPAR)-γ at day 14 of gesta-
tion (Figure 2).
Effect of LPS infusion and diet type on plasma FFA
concentration and plasma FA composition
Following LPS infusion at day 3 postpartum, both groups
had increased plasma FFA concentration with no differ-
ence observed between them (Figure 6). LPS infusion re-
sulted in increased plasma concentrations of C18:1n9,
C18:3n3, C18:2n6 and total n-6 PUFA in the SO-fed rats,
whereas no change was observed in the FO-fed rats. As a
result, the FO-fed rats still had higher plasma con-
centrations of C20:5n3, C22:6n3 and total n-3 PUFA, and
lower plasma concentrations of C18:2n6, C20:4n6, totaln-6 PUFA, SFA and FA than the SO-fed rats following
LPS infusion (Table 2).
Effect of diet type on inflammation mediators in
LPS-infused mammary glands
Mammary mRNA abundances of IL-1β, TNF-α and
XOR (Figure 7) as well as PMN prevalence (Figure 8)
were increased following LPS infusion at day 3 postpar-
tum, which was observed in the SO-fed rats rather than
in the FO-fed rats. Accordingly, mammary mRNA abun-
dances of IL-1β, TNF-α and XOR following LPS infusion
was lower in the FO-fed than in the SO-fed rats (Figure 7).
In contrast, mammary IL-10 mRNA abundance was higher
in the FO-fed than in the SO-fed rats, although it
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Figure 5 Histopathology of mammary glands of rats fed different diets at different reproductive stages. Hematoxylin and eosin stained
slides were made with mammary tissues collected from rats fed the SO diet (B) or FO diet (C) at day 0 and 14 of gestation. PMN prevalence (A)
in alveoli was estimated by using light microscopic (Olympus BH2, Japan) analysis at a magnification of 400×. Statistics are shown as means ± SE.
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Figure 6 Plasma FFA concentration of rats fed different diets and
challenged with different stimulus. Plasma FFA concentration was
determined by ELISA using plasma collected from rats fed the SO or FO
diet and challenged with saline or LPS. Statistics are shown as means ± SE.
Statistics with no common letters differ significantly (P < 0.05).
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The beneficial effects of FO have been documented
abundantly [13-15]. And evidences concerning n-3 PUFA
alleviating inflammation were persuasive [16-18]. How-
ever, the effect of dietary FO on attenuating mammary in-
flammation has not been verified. Thus, the present study
was focused on the mammary glands to test the anti-
inflammatory effect of dietary FO.
Given that inflammatory responses are in strong asso-
ciation with FA types such as n-6 and n-3 PUFA, we
firstly examined the plasma FA profile at different repro-
ductive stages of rats receiving different diets. An ampli-
fied plasma concentration of n-3 PUFA was observed
following FO consumption for 14 days in this study,
which agreed well with the previous study in horses by
Table 2 Plasma FA composition (μg/mL) of rats fed
different diets and challenged with different stimulus
Item1 SS SL FS FL Pooled SEM
C14:0 32.62ab 45.60a 21.11b 20.19b 13.95
C16:0 948.69a 1103.10a 373.53b 581.32b 231.72
C18:0 688.14a 791.68a 239.47b 401.64b 138.39
C20:0 13.32ab 17.10a 4.17c 8.11bc 4.04
SFA 1682.78a 1957.48a 634.11b 1003.14b 382.43
C16:1 57.58ab 80.16a 20.74c 43.88bc 23.12
C18:1n7 42.41ab 51.73a 22.75b 21.87b 19.09
C18:1n9 156.96b 218.23a 162.35b 195.47ab 36.77
C20:1 40.99ab 55.48a 5.41c 21.85bc 18.35
MUFA 297.94ab 405.60a 211.26b 283.07ab 86.41
C18:3n3 11.65b 21.24a 6.43b 8.32b 4.67
C20:5n3 8.00b 11.32b 95.75a 142.18a 41.03
C22:6n3 76.60c 96.50bc 146.34ab 161.66a 32.93
n-3PUFA 96.25b 129.05b 248.51a 312.16a 59.83
C18:2n6 262.59b 379.98a 169.54c 202.36bc 53.52
C20:4n6 400.24a 485.86a 197.67b 206.75b 79.46
n-6PUFA 662.83b 865.84a 367.21c 409.11c 117.17
TFA 2739.80ab 3357.97a 1465.26c 2015.59bc 519.16
abcValues in the same row assigned no common superscript letter differ
significantly (P < 0.05).
1SS, rats fed the SO diet and infused by saline; SL, rats fed the SO diet and
infused by LPS; FS, rats fed the FO diet and infused by saline; FL, rats fed the
FO diet and infused by LPS.
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plasma n-6 FA concentration in the FO-fed horses, but
little variation of plasma n-6 PUFA concentration was
observed in the FO-fed rats in this study. Noting that
the horses used in the study of Hall et al [19] consumed
FO for 6 weeks, a shorter consumption period (24 days)
in this study may explain the little variation of n-6
PUFA. In addition, it was verified in the present study
that substituting SO with FO resulted in higher plasma
n-3 PUFA concentration and lower concentrations of
SFA and n-6 PUFA. Amira et al [20] reported that de-
creased n-6/n-3 ratio led to higher plasma n-3 PUFA
concentration and lower n-6 PUFA concentration, which
was consistent with our results considering that the n-6/
n-3 ratio in our experimental diets was approximately
0.5:1 in the FO diet and 10:1 in the SO diet.
Another result in the present study was that up-
regulated plasma FFA emerged with the advance of ges-
tation. As FFA have been reported to be associated with
inflammation including mastitis [20,21], we further stud-
ied whether the advance of gestation was related to
the expression of inflammation mediators. In both diet
groups, the mRNA abundances of XOR and IL-8, protein
levels of IL-1β and TNF-α as well as PMN prevalenceall increased from day 0 of gestation to day 14 of gestation.
TNF-α, IL-8 and IL-1β are all known as pro-inflammatory
cytokines. Stimulated by a range of agents, TNF-α in-
duces other inflammatory mediators that participated
in inflammatory responses [22]. IL-8 can activate neu-
trophils to degranulate and induce tissue damage [23].
Moreover, IL-1β and TNF-α were elucidated to be key
mediators participating in the neutrophil recruitment
into the udder [24]. XOR is also an inflammatory indica-
tor that highly expressed in mammary tissues during
pregnancy and lactation [25,26]. Hence, we proposed that
the advance of pregnancy was accompanied by inflamma-
tory responses of the udder. Notably, compared with the
SO-fed rats, the FO-fed rats had lower mRNA levels
of XOR and TNF-α but higher mRNA levels of IL-10
and PPAR-γ, both of which are acknowledged as anti-
inflammatory mediators [27,28]. The down-regulation of
XOR and TNF-α may be induced by the lower SFA and
n-6 PUFA concentrations and higher n-3 PUFA concen-
trations in plasma. Consistent with this notion, it has
been shown that the decreased production of TNF was
accompanied by a decreased ratio of C20:4n6 to C20:5n3
in the membrane phospholipids of mononuclear cells,
which indicates the significance of systemic n-6/n-3 PUFA
profile in inflammatory responses [29].
Excited by the potential effect of FO in decreasing
pro-inflammatory cytokines in mammary glands, we fur-
ther determined the anti-inflammatory effect of FO with
a rat mastitis model. Rats at day 3 postpartum were in-
fused with LPS or saline. LPS challenge resulted in ele-
vated plasma FFA in both groups indicating the systemic
inflammation induced by LPS. However, only in the
SO-fed rats did LPS infusion stimulate the expression of
IL-1β, XOR and TNF-α. During the process of mammary
glands inflammation induced by advance of gestation as
well as by LPS infusion, the relatively lower level of mam-
mary pro-inflammatory mediators in the FO-fed rats may
result from higher total n-3 PUFA concentration and
lower SFA concentration in plasma. During lactation, the
mammary blood flow increased sharply [30] and the
mammary glands may become more susceptible to sub-
stances in the blood. Therefore, we assumed that the
relatively higher SFA concentration in the SO-fed rats
may lead to aggravated toxicity of LPS. On one hand,
LPS could activate the TLR4 pathway, free NF-κB [31]
and finally facilitate the expression of pro-inflammatory
cytokines in the mammary glands of the SO-fed rats. On
the other hand, the elevated XOR expression may en-
hance the generation of ROS which may participate in
the TLR4 dimerization and recruitment of TLR4 into
lipid rafts on condition that SFA were metabolized into
ceramide [9,10]. The higher levels of PPAR-γ and IL-10
in the FO-fed rats may block the TLR4 pathway, as eluci-


































































































































































Figure 7 Relative mRNA abundances of rats fed different diets and challenged with different stimulus. mRNA abundances of IL-1β (A),
TNF-α (B), XOR (C), IL-10 (D) and PPAR-γ (E) was determined by RT-PCR with mammary tissues collected from rats fed the SO or FO diet and
challenged with saline or LPS. Statistics are shown as means ± SE. Statistics with no common letters differ significantly (P < 0.05).
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secretion [34]. Moreover, it has been shown in HK-2 cells
that DHA and EPA can activate the mRNA expression of
PPAR-γ [35]. Meanwhile, n-3 PUFA and their metabolites
are natural ligands for PPAR-γ [36] and DHA for
example can be metabolized by oxygenase to 17-OH
and 7-OH-DHA thus facilitates PPAR-γ activation
[37]. Therefore, n-3 PUFA can upregulate PPAR-γ
expression and promote PPAR-γ functioning. Noticeably,
maternal PPAR-γ was demonstrated to be pivotal for pro-
tecting the nursing newborns by suppressing the productionof inflammatory lipids in the lactating mammary glands
[38]. Additionally, it was assumed that IL-10 may inhibit
the production of TNF-α and IL-6 in the mammary glands
[39]. Therefore, we postulated that FO might down-regulate
the mRNA expression of IL-1β, XOR and TNF-α through
enhancing the expression of IL-10 and PPAR-γ.
Conclusions
This study suggested that mammary inflammation in-
duced by pregnancy proceeding and pathogen challenge
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Figure 8 Histopathology of mammary glands of rats fed different diets and challenged with different stimulus. Hematoxylin and eosin
stained slides were made with mammary tissues collected from rats fed the SO diet (B) or FO diet (C) and challenged with saline or LPS. PMN
prevalence (A) in alveoli was estimated by using light microscopic (Olympus BH2, Japan) analysis at a magnification of 400×. Statistics are shown
as means ± SE. Statistics with no common letters differ significantly (P < 0.05).
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elicited by FO consumption in ameliorating the mammary
inflammation.
Methods
Animals, diets and treatments
All experimental protocols were approved by the Animal
Care and Use Committee of Sichuan Agricultural Univer-
sity, and were in accordance with the National Research
Council’s Guide for the Care and Use of Laboratory
Animals. The experimental rats (Virgin female Sprague-
Dawley rats) were purchased from Sichuan Academy
of Medical Sciences-Sichuan Provincial People’s Hospital
Experimental Animal Research Institute, and housed in-
dividually in metallic cages in a temperature controlled(22 ± 2°C) room with a 12 h light/dark cycle and rela-
tive humidity was maintained at 60 ± 10%.
Experimental diets (Table 3) were formulated to meet
or exceed the nutrient requirements of gestating and lac-
tating rats as recommended by AIN-93G. To create dif-
ference in inclusion levels of dietary SFA and n-3 PUFA
and to make sure the two diets were isocaloric, the 7 kg
fat included in the experimental diets was composed of
7 kg soybean oil (SO) in the SO diet, and 5 kg fish oil
(FO), 1 kg lard and 1 kg SO in the FO diet. The FA com-
position of the two types of oil and experimental diets is
shown in Table 4. To avoid PUFA oxidation, all diets
were stored at -20 C.
At the beginning of the experiment, all female rats were
housed together with male rats to complete mating. When
Table 4 FA composition of oil (g/100 g) and diets (g/kg)
(as fed basis)
Fatty acids SO FO SO diet FO diet
C14:0 0.05 0.92 0.09 0.39
C16:0 10.93 9.05 5.25 5.49
C18:0 2.25 1.60 2.03 2.05
C20:0 0.02 0.12 0.20 0.07
C16:1 0.09 6.14 0.06 2.00
C18:1 27.43 23.00 11.72 10.77
C20:1 0.03 3.06 0.22 1.04
C22:1 ND1 2.31 0.23 0.78
C18:2n6 52.00 2.27 22.54 4.67
C18:3n3 5.80 1.49 2.18 0.68
C20:5n3 ND 21.90 0.225 4.48
C22:6n3 ND 14.60 ND 2.84
Other 1.40 13.54 0.26 2.76
∑FA 2 100 100 45 38
∑SFA 3 13.25 11.69 7.57 8.00
∑MUFA 4 27.55 34.51 12.23 14.58
∑PUFA 5 57.80 40.26 24.94 12.66
∑SFA/∑FA 13.25 11.69 16.82 21.05
∑MUFA/∑FA 27.55 34.51 27.18 38.37
∑PUFA/∑FA 57.80 40.26 55.43 33.32
∑n-3 6 5.8 37.99 2.41 7.99
∑n-6 7 52 2.27 22.54 4.67
∑n-6/∑n-3 8.97 0.06 9.36 0.58
1ND, Not detected.
2∑FA means the sum of content of all fatty acids evaluated.
3∑SFA means the sum of C14:0, C16:0, C18:0 and C20:0 content.
4∑MUFA means the sum of C16:1, C18:1, C20:1 and C22:1 content.
5∑PUFA means the sum of C18:2n6, C18:3n3, C20:5n3 and C22:6n3 content.
6∑n-3 means the sum of C18:3n3, C20:5n3 and C22:6n3 content.
7∑n-6 means the content of C18:2n6.
Table 3 Ingredients and composition of experimental
diets (air-dry basis)
Ingredients Content (%) Composition Content (%)
Corn starch 39.75 Crude protein 16.23
Casein 20 ME, Mcal/kg 3.81
Gelatinization starch 13.2 Lysine 1.53
Sucrose 10 Methionine 0.57









1The 7 kg fat was composed of 7 kg SO in the SO diet, and 5 kg FO, 1 kg lard
and 1 kg SO in the FO diet.
2Provided per kg of diet: Calcium 5000 mg, Phosphorus 1561 mg, Potassium
3600 mg, sodium 1019 mg, Chlorine 1517 mg, magnesium 510 mg, Rion35
mg, Zinc 30 mg, Manganese 10 mg, Copper 6 mg, Selenium 0.15 mg,
Iodine 0.2 mg.
3Provided per kg of diet: Vitamin A 4 000 IU, Vitamin D3 1000 IU, Vitamin K3
0.75 mg, Vitamin B1 6.0 mg, Vitamin B2 7.0 mg, Vitamin B6 6.0 mg, Vitamin B12
0.02 mg, nicotinic acid 30.0 mg, D-calcium pantothenate 15.3 mg, folic acid
2.0 mg, biotin 0.2 mg.
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ing, then that day was designated as day 0 of gestation.
Forty-eight rats after mating were housed individually
and began to receive the SO or FO diets. Blood and
mammary tissue samples (n = 6) at day 0 and 14 of
gestation and day 3 postpartum, respectively, were col-
lected 9 hours after intramammary infusion of LPS ac-
cording to the work of Miao et al [40]. The infusion
was conducted according to the methods of Zhong et al
[41]. Briefly, the inguinal mammary glands of rats were
infused with 0 or 10 μg E.coli LPS (O55:B5, Sigma,
USA) dissolved in 100 μl sterile, pyrogen-free, physio-
logical saline. Blood samples were collected (after 12-h
fast and following isoflurane anesthesia) through intra-
orbital bleeding for the separation of plasma and then
stored at −20°C until analysis. The fourth mammary
glands were cut with scissors, and then the left and right
mammary glands were snap frozen in lipid nitrogen and
stored at -80°C or fixed in 4% paraformaldehyde and
stored at 4°C respectively.
FA composition analysis
Plasma FA composition was determined according to
the methods described by Fernández-Real et al [42] with
modification. In brief, 30-50 mg weighed plasma sample
was mixed with four milliliter acetyl chloride and metha-
nol solution (1:10, vol/vol). Transesterification was con-
ducted and the pooled solvent extracts were dried bynitrogen at room temperature. The residues were dis-
solved in 5 ml hexane with internal standard and sub-
jected to water bath at 80°C for 2 hours. Then 7%
potassium carbonate was added, and supernatant was
collected for analysis. Hewlett-Packard 6890 gas chro-
matograph equipped with a flame ionization detector
was used to analyze the FA composition, and helium
was used as carrier gas. The injector temperature was
programmed at 250°C and the detector temperature was
270°C.
FFA analysis
A commercial ELISA kit (GBD, USA) was used to deter-
mine plasma free fatty acids (FFA) concentration as de-
scribed by the manufacturer’s protocols. All assays were
conducted in 96-well plates and absorbance at 450 nm
was detected with a microplate reader. FFA values were
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from the corresponding absorbance of the standard
reagent.
RNA extraction and real-time PCR
The mRNA abundances of the mammary gland samples
were measured by real-time polymerase chain reac-
tion (PCR) as previously described [43]. Total RNA
was extracted using a TRIZOL Reagent kit (Invitrogen,
Carlsbad, CA). The cDNA was prepared using a reverse
transcription (RT) kit (TAKARA, Japan) following the
manufacture’s instruction. Primers were synthesized by
Chengdu Tiantai Biological Company (Chengdu, China).
Βeta-actin was used as an internal control according to
the work of Gu et al [43]. The nucleotide primer se-
quences are listed in Table 5. Quantitative real-time
RT-PCR analysis was performed using a 7900 real-time
PCR system (Applied Biosystems, USA) and SYBR Green
assays (Master Mix SYBR® Green TAKARA, Japan). The
specificity of PCR products were examined with melting
curve analysis. Results (fold changes) were expressed
as 2−ΔΔCt with ΔΔCt = (Ct ij − Ct β-actin j) − (Ct i1 −
Ct β-actin1), where Ct ij and Ct β-actin j are the Ct for
gene i and for β-actin in a sample (named j), and where
Ct i1 and Ct β-actin1 are the Ct in sample 1, expressed as
the standard.
Histopathologic examination
Mammary tissue samples fixed in 4% paraformaldehyde
for 24 h were further processed with standard dehydra-
tion and paraffin-wax embedding procedures to produce
tissue blocks. Hematoxylin and eosin stained slides were















Reverse gctcagtaacagtccgcctagaapolymorphonuclear neutrophils (PMN) in alveoli was esti-
mated by using light microscopic (Olympus BH2, Japan)
analyses at a magnification of 400× as previously described
[40]. Briefly, four sections of mammary tissues were chosen
for each rat. Ten fields were randomly selected per sample.
Results were presented as average PMN infiltration scores
for each time point.
Immunohistochemistry
Polyclonal antibodies combined with the avidin-
biotinperoxidase complex (ABC) technique were used for
the immunohistochemical detection of interleukin (IL)-1β
(Abnova, USA) and tumor necrosis factor (TNF)-α (Novus,
USA). All samples from one animal were analyzed within
the same assay run, and within each assay run treatment
animals to be compared were included. The quantification
of IL-1β and TNF-α protein expression in mammary tissue
samples was performed as described [44]. For each sample,
a relative value of the amount of cytokine produced was
expressed as the average percentage of the positively
stained areas.
Statistic analysis
All statistical evaluation was performed by using the
General Linear Model procedures of SAS statistical pack-
age (V8.1, SAS Institute Inc., Cary, NC). The statistic
model used is as follows: Yijk = μ +Ai +Bj + (A ×B)ij + εijk,
where Y is the analysed variable, μ the overall mean, A the
effect of diet, B the effect of time or LPS, A ×B the effect
of diet × time or LPS interaction, and ε the random error.
Least-squares means comparison was used to evaluate dif-
ferences among treatments. P values ≤ 0.05 were consid-
ered statistical significance.ed to amplify cytokines and a house keeping gene
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